Search Results - "VON EULER, Mikael" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival

Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival

by Pesonen, Sari, Lundin, Johan, Linder, Nina, Turkki, Riku, Ristimäki, Ari, Joensuu, Timo, Kairemo, Kalevi, Partanen, Kaarina, Alanko, Tuomo, Jäger, Elke, Karbach, Julia, Wahle, Claudia, Hemminki, Akseli, Backman, Charlotta, von Euler, Mikael, Hakonen, Tiina, Ranki, Tuuli, Vuolanto, Antti, Jäderberg, Magnus, Zamarin, Dmitry
Published in Journal for immunotherapy of cancer (04.11.2015)

Get full text

Journal Article

Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers

Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers

by Ranki, Tuuli, Pesonen, Sari, Hemminki, Akseli, Partanen, Kaarina, Kairemo, Kalevi, Alanko, Tuomo, Lundin, Johan, Linder, Nina, Turkki, Riku, Ristimäki, Ari, Jäger, Elke, Karbach, Julia, Wahle, Claudia, Kankainen, Matti, Backman, Charlotta, von Euler, Mikael, Haavisto, Elina, Hakonen, Tiina, Heiskanen, Raita, Jaderberg, Magnus, Juhila, Juuso, Priha, Petri, Suoranta, Laura, Vassilev, Lotta, Vuolanto, Antti, Joensuu, Timo
Published in Journal for immunotherapy of cancer (15.03.2016)

Get full text

Journal Article

$Gene expression analysis of tumors demonstrates an induction of Th1 type immune response following intratumoral administration of ONCOS-102 in refractory solid tumor patients$

Gene expression analysis of tumors demonstrates an induction of Th1 type immune response following intratumoral administration of ONCOS-102 in refractory solid tumor patients

by Majumder, Mamun, Kumar, Ashwini, Heckman, Caroline, Kankainen, Matti, Pesonen, Sari, Jäger, Elke, Karbach, Julia, Joensuu, Timo, Kairemo, Kalevi, Partanen, Kaarina, Alanko, Tuomo, Hemminki, Akseli, Backman, Charlotta, Dienel, Kasper, von Euler, Mikael, Hakonen, Tiina, Juhila, Juuso, Ranki, Tuuli, Vassilev, Lotta, Vuolanto, Antti, Jaderberg, Magnus
Published in Journal for immunotherapy of cancer (06.11.2014)

Get full text

Journal Article

Molecule based diagnosis

Molecule based diagnosis

by Akaza, Hideyuki, Ichikawa, Tomohiko, Tsuruo, Takashi, Shimada, Yasuhiro, Moriwaki, Hisataka, Mori, Masaki, Noguchi, Shinzaburo, Nakamura, Seigo, Saijo, Nagahiro, Sone, Saburo, Isonishi, Seiji, Ohashi, Yasuo, Hinotsu, Shiro, von Euler, Mikael, Blackedge, George
Published in Gan to kagaku ryoho (01.01.2004)

Get more information

Journal Article

Post launch studies

Post launch studies

by Akaza, Hideyuki, Ohashi, Yasuo, Shimada, Yasuhiro, Ikeda, Tadashi, Saijo, Nagahiro, Isonishi, Seiji, Hirao, Yoshihiko, Tsuruo, Takashi, Tsukagoshi, Shigeru, Sone, Saburo, Nakamura, Seigo, Kato, Masuhiro, Mikami, Osamu, von Euler, Mikael, Blackledge, George, Milsted, Bob, Vose, Brent
Published in Gan to kagaku ryoho (01.11.2002)

Get more information

Journal Article

Globalization of clinical trials

Globalization of clinical trials

by Akaza, Hideyuki, Fukuoka, Masahiro, Ohtsu, Atsushi, Usami, Michiyuki, Ikeda, Tadashi, Aiba, Keisuke, Isonishi, Seiji, Ohashi, Yasuo, Saijo, Nagahiro, Sone, Saburo, Tsukagoshi, Shigeru, Tsuruo, Takashi, Kato, Masuhiro, Mikami, Osamu, Dong, Rui-Ping, von Euler, Mikael, Blackledge, George, Stribling, Don
Published in Gan to kagaku ryoho (01.04.2003)

Get more information

Journal Article

Frequency of comedication of proton pump inhibitors with crystalline dasatinib in chronic myeloid leukemia and effects on TKI-bioavailability

Frequency of comedication of proton pump inhibitors with crystalline dasatinib in chronic myeloid leukemia and effects on TKI-bioavailability

by Dahlén, Torsten, Larfors, Gunnar, Lennernäs, Hans, Liljebris, Charlotta, Von Euler, Mikael, Brisander, Magnus, Andersson, Per, Stenke, Leif
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2024)

Get full text

Journal Article Conference Proceeding

Comparable pharmacokinetics of 85 mg RightSize nilotinib (XS003) and 150 mg Tasigna in healthy volunteers using a hybrid nanoparticle-based formulation platform for protein kinase inhibitors

Comparable pharmacokinetics of 85 mg RightSize nilotinib (XS003) and 150 mg Tasigna in healthy volunteers using a hybrid nanoparticle-based formulation platform for protein kinase inhibitors

by Andersson, Per, Von Euler, Mikael, Beckert, Michael
Published in Journal of clinical oncology (20.05.2014)

Get full text

Journal Article

Abstract 2523: Strong synergistic effects with APR-246 and cisplatin in p53-mutant lung cancer cells

Abstract 2523: Strong synergistic effects with APR-246 and cisplatin in p53-mutant lung cancer cells

by Mohell, Nina, Fransson, Åsa, Alfredsson, Jessica, von Euler, Mikael, Björklund, Ulf, Abrahmsen, Lars
Published in Cancer research (Chicago, Ill.) (01.08.2015)

Get full text

Journal Article

Anastrozole is superior to tamoxifen as first‐line therapy in hormone receptor positive advanced breast carcinoma

Anastrozole is superior to tamoxifen as first‐line therapy in hormone receptor positive advanced breast carcinoma

by Bonneterre, Jacques, Buzdar, Aman, Nabholtz, Jean‐Marc A., Robertson, John F. R., Thürlimann, Bert, von Euler, Mikael, Sahmoud, Tarek, Webster, Alan, Steinberg, Mark
Published in Cancer (01.11.2001)

Get full text

Journal Article

Abstract 270: Synergistic effect with APR-246 and standard chemotherapy in small cell lung cancer cells carrying smoking-associated TP53 mutations

Abstract 270: Synergistic effect with APR-246 and standard chemotherapy in small cell lung cancer cells carrying smoking-associated TP53 mutations

by Mohell, Nina, Fransson, Åsa, Alfredsson, Jessica, von Euler, Mikael, Björklund, Ulf, Abrahmsen, Lars
Published in Cancer research (Chicago, Ill.) (15.07.2016)

Get full text

Journal Article

Abstract 1801: APR-246, a clinical-stage mutant p53-reactivating compound, resensitizes ovarian cancer cells to platinum compounds and doxorubicin

Abstract 1801: APR-246, a clinical-stage mutant p53-reactivating compound, resensitizes ovarian cancer cells to platinum compounds and doxorubicin

by Mohell, Nina, Alfredsson, Jessica, Fransson, Åsa, Bykov, Vladimir, Euler, Mikael von, Wiman, Klas, Björklund, Ulf
Published in Cancer research (Chicago, Ill.) (01.10.2014)

Get full text

Journal Article

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis

by BONNETERRE, Jacques, BUZDAR, Aman, NABHOLTZ, Jean-Marc A, ROBERTSON, John F. R, THÜRLIMANN, Bert, VON EUTER, Mikael, SAHMOUD, Tarek, WEBSTER, Alan, STEINBERG, Mark
Published in Cancer (01.11.2001)

Get full text

Journal Article

EUTROC PiSARRO: A phase Ib study combining APR-246 with standard chemotherapy in platinum sensitive relapsed high grade serous ovarian carcinoma (HGSOC)

EUTROC PiSARRO: A phase Ib study combining APR-246 with standard chemotherapy in platinum sensitive relapsed high grade serous ovarian carcinoma (HGSOC)

by Gourley, Charlie, Gabra, Hani, Vergote, Ignace, Basu, Bristi, Brenton, James, Von Euler, Mikael, Björklund, Ulf, Smith, Austin M., Green, John
Published in Journal of clinical oncology (20.05.2015)

Get full text

Journal Article

PISARRO: A EUTROC phase Ib study of APR-246 in combination with carboplatin (C) and pegylated liposomal doxorubicin (PLD) in platinum sensitive relapsed high grade serous ovarian cancer (HGSOC)

PISARRO: A EUTROC phase Ib study of APR-246 in combination with carboplatin (C) and pegylated liposomal doxorubicin (PLD) in platinum sensitive relapsed high grade serous ovarian cancer (HGSOC)

by Gourley, Charlie, Green, John, Gabra, Hani, Vergote, Ignace, Basu, Bristi, Brenton, James D., Björklund, Ulf, Smith, Austin M., Von Euler, Mikael
Published in Journal of clinical oncology (20.05.2016)

Get full text

Journal Article

Abstract CT204: Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer

Abstract CT204: Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer

by von Euler, Mikael, Wiman, Klas G., Gabra, Hani, Brenton, James D., Basu, Bristi, Vergote, Ignace, Gourley, Charlie, Smith, Austin, Alfredsson, Jessica, Mohell, Nina, Green, John A.
Published in Cancer research (Chicago, Ill.) (01.08.2015)

Get full text

Journal Article

Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8 + T-cell response, prominent infiltration of CD8 + lymphocytes and Th1 type polarization

Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8 + T-cell response, prominent infiltration of CD8 + lymphocytes and Th1 type polarization

by Ranki, Tuuli, Joensuu, Timo, Jäger, Elke, Karbach, Julia, Wahle, Claudia, Kairemo, Kalevi, Alanko, Tuomo, Partanen, Kaarina, Turkki, Riku, Linder, Nina, Lundin, Johan, Ristimäki, Ari, Kankainen, Matti, Hemminki, Akseli, Backman, Charlotta, Dienel, Kasper, von Euler, Mikael, Haavisto, Elina, Hakonen, Tiina, Juhila, Juuso, Jaderberg, Magnus, Priha, Petri, Vassilev, Lotta, Vuolanto, Antti, Pesonen, Sari
Published in Oncoimmunology (01.11.2014)

Get full text

Journal Article

$An evaluation of local and systemic immune markers following intratumoral administration of a chimeric adenovirus Ad5/3-D24-GMCSF in refractory cancer patients with solid tumors$

An evaluation of local and systemic immune markers following intratumoral administration of a chimeric adenovirus Ad5/3-D24-GMCSF in refractory cancer patients with solid tumors

by Pesonen, Sari Anneli, Ranki, Tuuli, Jäger, Elke, Karbach, Julia, Wahle, Claudia, Joensuu, Timo K., Alanko, Tuomo, Partanen, Kaarina, Kairemo, Kalevi, Turkki, Riku, Linder, Nina, Lundin, Johan, Ristimäki, Ari, Majumder, Mamun, Kumar, Ashwini, Heckman, Caroline, Kankainen, Matti, Hemminki, Akseli, Von Euler, Mikael, Jaderberg, Magnus Erik
Published in Journal of clinical oncology (20.05.2015)

Get full text

Journal Article

$CGTG-102 (Ad5/3-D24-GMCSF), a novel oncolytic adenovirus, in patients with refractory solid tumors: Experience from an advanced therapy access program$

CGTG-102 (Ad5/3-D24-GMCSF), a novel oncolytic adenovirus, in patients with refractory solid tumors: Experience from an advanced therapy access program

by Von Euler, Mikael, Kanerva, Anna, Nokisalmi, Petri, Koski, Anniina, Diaconu, Iulia, Cerullo, Vincenzo, Joensuu, Timo K., Oksanen, Minna, Pesonen, Sari, Kangasniemi, Lotta, Ranki, Tuuli, Heiskanen, Raita, Hemminki, Akseli
Published in Journal of clinical oncology (20.05.2012)

Get full text

Journal Article

Single subcutaneous administration of chorionic gonadotropin to rats induces a rapid and transient increase in testicular expression of pro-inflammatory cytokines

Single subcutaneous administration of chorionic gonadotropin to rats induces a rapid and transient increase in testicular expression of pro-inflammatory cytokines

by ASSMUS, Monique, SVECHNIKOV, Konstantin, VON EULER, Mikael, SETCHELL, Brian, SULTANA, Taranum, ZETTERSTRÖM, Cecilia, HOLST, Mikael, KIESS, Wieland, SODER, Olle
Published in Pediatric research (01.06.2005)

Get full text

Journal Article